Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ)

CAPS Rating: 3 out of 5

A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.

Recs

0
Player Avatar HIGHG33K (73.68) Submitted: 7/9/2012 3:33:53 PM : Outperform Start Price: $45.37 JAZZ Score: +16.42

With hot biotech sector and decent value.

Featured Broker Partners


Advertisement